S M Al-Habet - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

The American Review of Respiratory Disease|November 1, 1986

Angiotensin-converting enzyme. Investigation of diurnal variation, the effect of a large dose of prednisolone, and prednisolone pharmacokinetics in patients with sarcoidosisP J Thompson, M W Kemp, W A McAllister, et al.

Clinical Pharmacology and Therapeutics|September 1, 1993

Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillinJ P Wang, J D Unadkat, S M al-Habet, et al.

Clinical Pharmacology and Therapeutics|September 1, 1993

Disposition of drugs in cystic fibrosis. V. In vivo CYP2C9 activity as probed by (S)-warfarin is not enhanced in cystic fibrosisT A O'Sullivan, J P Wang, J D Unadkat, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

The American Review of Respiratory Disease|November 1, 1986

Angiotensin-converting enzyme. Investigation of diurnal variation, the effect of a large dose of prednisolone, and prednisolone pharmacokinetics in patients with sarcoidosisP J Thompson, M W Kemp, W A McAllister, et al.

Clinical Pharmacology and Therapeutics|September 1, 1993

Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillinJ P Wang, J D Unadkat, S M al-Habet, et al.

Clinical Pharmacology and Therapeutics|September 1, 1993

Disposition of drugs in cystic fibrosis. V. In vivo CYP2C9 activity as probed by (S)-warfarin is not enhanced in cystic fibrosisT A O'Sullivan, J P Wang, J D Unadkat, et al.

Pageof 2